Kodiak Sciences Inc — Quarterly Cash Flow (NASDAQ:KOD) | MetaTrader

Open full chart

Financials

Overview 성명 Statistics Dividends

Quarterly Annual

Total assets 372.67 M335.58 M297.91 M256.73 M218.07 M Total liabilities 187.3 M185.29 M189.07 M186.44 M194.38 M Total equity 185.37 M150.29 M108.84 M70.29 M23.69 M Total liabilities & shareholders' equities 372.67 M335.58 M297.91 M256.73 M218.07 M Total debt ————— Net debt —————

뉴스

코디악 사이언스, 목표가 38달러에 매수 의견 유지

H.C. Wainwright reiterates Buy rating on Kodiak Sciences stock at $38

Kodiak Sciences Inc. (KOD) Presents at Angiogenesis, Exudation, and Degeneration 2026 - Slideshow (NASDAQ:KOD) 2026-02-09

KOD Stock Up 24% in 3 Months: Here's What You Need to Know

코디악 사이언스, 혈관신생 학회에서 APEX 최종 연구 결과 발표 예정

Kodiak Sciences to present final APEX study results at Angiogenesis meeting

코디악 사이언스 목표 주가, H.C. Wainwright서 38달러로 상향

Kodiak Sciences stock price target raised to $38 from $26 at H.C. Wainwright

Alphabet To Rally Around 22%? Here Are 10 Top Analyst Forecasts For Thursday - Callaway Golf (NYSE:CALY), Datadog (NASDAQ:DDOG)

Kodiak Sciences Inc. (KOD) Presents at 44th Annual J.P. Morgan Healthcare Conference - Slideshow (NASDAQ:KOD) 2026-01-21

Kodiak Sciences Inc. (KOD) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript

UBS, 코디악 사이언스에 ’매수’ 등급 제시, 목표가 $50